DK0682522T3 - Fremgangsmåde til fremstilling af farmaceutiske præparater indeholdende vecuroniumbromid - Google Patents

Fremgangsmåde til fremstilling af farmaceutiske præparater indeholdende vecuroniumbromid

Info

Publication number
DK0682522T3
DK0682522T3 DK94906925.6T DK94906925T DK0682522T3 DK 0682522 T3 DK0682522 T3 DK 0682522T3 DK 94906925 T DK94906925 T DK 94906925T DK 0682522 T3 DK0682522 T3 DK 0682522T3
Authority
DK
Denmark
Prior art keywords
vial
pct
date aug
vecuronium bromide
analogue
Prior art date
Application number
DK94906925.6T
Other languages
Danish (da)
English (en)
Inventor
Frans Herwig Jan Jansen
Original Assignee
Curamed Pharma Gmbh
Inpharm Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curamed Pharma Gmbh, Inpharm Nv filed Critical Curamed Pharma Gmbh
Application granted granted Critical
Publication of DK0682522T3 publication Critical patent/DK0682522T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK94906925.6T 1993-02-08 1994-02-08 Fremgangsmåde til fremstilling af farmaceutiske præparater indeholdende vecuroniumbromid DK0682522T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302455A GB9302455D0 (en) 1993-02-08 1993-02-08 Process for preparing a pharmaceutical preparation having neuromuscular blocking activity

Publications (1)

Publication Number Publication Date
DK0682522T3 true DK0682522T3 (da) 1996-10-07

Family

ID=10730043

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94906925.6T DK0682522T3 (da) 1993-02-08 1994-02-08 Fremgangsmåde til fremstilling af farmaceutiske præparater indeholdende vecuroniumbromid

Country Status (15)

Country Link
US (1) US5681573A (fr)
EP (1) EP0682522B1 (fr)
JP (1) JPH08508244A (fr)
AT (1) ATE137971T1 (fr)
AU (1) AU688305B2 (fr)
CA (1) CA2152262C (fr)
DE (1) DE69400190T2 (fr)
DK (1) DK0682522T3 (fr)
ES (1) ES2089924T3 (fr)
GB (1) GB9302455D0 (fr)
GR (1) GR3020815T3 (fr)
HU (1) HU213468B (fr)
NO (1) NO952666L (fr)
NZ (1) NZ261582A (fr)
WO (1) WO1994017808A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271031B (it) * 1994-10-21 1997-05-26 Poli Ind Chimica Spa Composizioni farmaceutiche miorilassanti
US5767112A (en) * 1994-10-21 1998-06-16 Poli Industria Chimica, S.P.A. Muscle relaxant pharmaceutical compositions
AU4428900A (en) * 1999-01-28 2000-08-18 Shshikant Prabhudas Kurani Novel injectable muscle relaxant formulations
DE102005030423A1 (de) * 2005-06-30 2007-01-04 Inresa Arzneimittel Gmbh Neue Formulierung für Vecuroniumbromid
CN101843593B (zh) * 2009-03-27 2011-12-21 西安力邦制药有限公司 一种维库溴铵冻干制剂及其制备方法
JP2016121073A (ja) * 2014-12-24 2016-07-07 ニプロ株式会社 注射剤用医薬組成物の製造方法
CN107638391B (zh) * 2016-07-22 2020-10-16 海南合瑞制药股份有限公司 一种注射用苯磺顺阿曲库铵组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138605A (en) * 1965-02-19 1969-01-01 Organon Labor Ltd Improvements in or relating to new 2-ß,16-ß-diamino-androstanes
EP0008824B1 (fr) * 1978-09-05 1982-04-28 Akzo N.V. Sels d'addition acides de 2-bêta, 16-bêta-bis pipéridino-androstane-16 bêta-monoammonium quaternaire et préparations pharmaceutiques les contenant
GB8708886D0 (en) * 1987-04-14 1987-05-20 Akzo Nv 2beta-morpholino-androstane derivatives
US5030633A (en) * 1990-09-12 1991-07-09 Williams Charles H Use of androstane derivative against malignant hyperthermia
US5418226A (en) * 1992-04-22 1995-05-23 Akzo N.V. Monoquaternary 2,16-bispiperidinylandrostane derivatives

Also Published As

Publication number Publication date
EP0682522B1 (fr) 1996-05-15
GR3020815T3 (en) 1996-11-30
NZ261582A (en) 1997-02-24
CA2152262A1 (fr) 1994-08-18
ES2089924T3 (es) 1996-10-01
WO1994017808A1 (fr) 1994-08-18
DE69400190T2 (de) 1996-12-12
HU213468B (en) 1997-06-30
US5681573A (en) 1997-10-28
HUT72444A (en) 1996-04-29
NO952666D0 (no) 1995-07-05
EP0682522A1 (fr) 1995-11-22
JPH08508244A (ja) 1996-09-03
AU688305B2 (en) 1998-03-12
ATE137971T1 (de) 1996-06-15
NO952666L (no) 1995-07-05
GB9302455D0 (en) 1993-03-24
CA2152262C (fr) 1999-08-17
DE69400190D1 (de) 1996-06-20
AU6039594A (en) 1994-08-29

Similar Documents

Publication Publication Date Title
JP3031570B2 (ja) 安定化されたゴナドトロピンを含有する調製品
KR890004718A (ko) 안정한 인체 단백질의 제조
EA200700389A1 (ru) Стабильный при хранении инфузионный раствор дигидроптеридинонов
SE8403487L (sv) Farmaceutisk komposition
RU94046251A (ru) Глюкагоноподобный пептид и производные инсулино-тропина, способ получений, фармацевтические композиции, способы лечения диабета
DK280884D0 (da) Galeniske praeparatformer for orale antidiabetica og fremgangsmaade til deres fremstilling
DK1196430T3 (da) Rensning og stabilisering af peptider og proteiner i farmaceutiske midler
KR920019371A (ko) 안정화된 인자 ⅷ 제제
ATE311227T1 (de) Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne
KR970061270A (ko) 히토성장호르몬을 함유하는 의약제제
HUP9900751A2 (hu) Parathormontartalmú stabil gyógyászati készítmény
DK0682522T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater indeholdende vecuroniumbromid
DE69111205D1 (de) Stabilisierung von Calcitonin enthaltenden pharmazeutischen Verbindungen.
DE3773017D1 (de) Nicorandil enthaltende zubereitung zum einspritzen.
ES450583A1 (es) Un procedimiento de preparacion de una solucion acuosa in- yectable de acido acetilsalicilico.
HUP9603489A2 (hu) Gyógyszerkészítmény és eljárás előállítására
SK53597A3 (en) A storage stable water solution for infusion containing a thrombin inhibitor
EA000211B1 (ru) Фармацевтические композиции для парентерального применения, содержащие индолкарбоновые кислоты
RU99100703A (ru) Модифицированная форма гидрохлорида r(-)-n -(4,4-ди(3-метил-тиен-2-ил)бут-3- енил)-нипекотиновой кислоты
JPH0678241B2 (ja) ｔＰＡ医薬組成物
ATE207437T1 (de) Auflösungssystem für eine wirkstoffhaltige flüssige lösung
SU1706627A1 (ru) "Средство дл стерилизации и кастрации самцов млекопитающих разного возраста "Канафен Б"
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
TH19245A (th) วิธีป้องกันการสลายของโปรตีนซี
SE9901634D0 (sv) Treatment of myocardial infarction with a substance related to the growth hormone axis